CD8A and neoplasm: Consequently, the feasibility of combined IRE with immunotherapy, coined as ‘electroimmunotherapy’ [226], was examined in pre-clinical immunocompetent PDAC murine models, resulting in significant tumor regression, increased CD8+ T cell infiltration and improved survival [137,227,228,229].